carboplatin,etoposide,atezolizumab,tiragolumab
roche
['skyscraper-02', 'lcsm,(-blcsm)', 'atezo', 'tiragolumab', 'sclc']
 summary of day 3 #lcsm abstracts #asco22 1. skyscraper-02, p3, presented by tiragolumab vs placebo +atezo+chemo 1st line for es-sclc no difference in os or pfs no major diff in aes between 2 arms 
Chief Hem/Onc Fellow @HFHemOncFellows | #ASCOTrainee | Former IM Resident @michiganstateu | @UJ_MED Alum | #LCSM?????? | Girl Dad???? | ????????????